Chinese medicine yin-yang; Peptide arrays fight terrorists;

> Tianyin Pharmaceutical, a maker of modernized traditional Chinese medicines, has received GMP certification for a new production facility from China's State Food and Drug Administration. Release

> Arrayit Corp. will provide its proprietary peptide microarray manufacturing platform to the U.S. Centers for Disease Control and Prevention for use in deciphering and combating infectious agents from terrorist attacks. Announcement

> Some 400 manufacturing jobs have been cut at a Teva plant in Prague, to be replaced next year by 300 jobs following a main plant expansion. Release

> Dionex, a maker of liquid chromatography analysis systems, is picking up HPLC assets from ESA Biosciences. Announcement

> Vetter of Ravensburg, Germany, is opening a 25,000-square-foot customer service facility in Chicago for the aseptic filling of very small quantities of injection products.  Release

Suggested Articles

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will get a new $176 million plant.

Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing. 

The FDA has found some issues with Biocon’s small molecule plant in Bengaluru, India.